Please Wait a Moment
X

Articles

07Aug

FDA Releases ZIKV Guidance and Grifols ZIKV Assay Licensed- August 8th Update

07 Aug, 2018 | Return|

CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.

Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications

Related

Preparing for Hurricane Florence

As the US coast prepares for Hurricane Florence to make landfall, we have received importan...

Read More >

The Reentry Changes Q & A document is now available

The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...

Read More >

FDA Releases Zika Virus (ZIKV) Guidance and Grifols ZIKV Assay Licensed

On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...

Read More >

FDA Guidance for Industry for Babesia

On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...

Read More >

Discontinue HIV-1 IFA Confirmatory Test

CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...

Read More >

Reminder- Check flights and cargo hours for the New Year holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for hol...

Read More >